Several Phase 1 and Phase 2 trials report encouraging results this month, amplifying momentum in precision psychiatry, respiratory …
Several Phase 1 and Phase 2 trials report encouraging results this month, amplifying momentum in precision psychiatry, respiratory …
New data from India suggest that Hillchol, an oral cholera vaccine by Bharat Biotech, is safe, effective and …
Researchers propose a new framework that combines domestic real-world data with overseas trial data to make global clinical …
In May 2025, a gene therapy for Rett syndrome has cleared major regulatory design review and is activating …
Oral brain-penetrant NLRP3 inhibitor and new collaborations place BioAge at center of metabolic aging drug development
Phase 2 study for Caliway’s CBL-514 highlights significant progress for Dercum’s disease, a rare and painful condition with …
Phase III ASCENT-04/KEYNOTE-D19 trial reveals meaningful PFS improvement with a novel antibody-drug conjugate/immunotherapy combo
MaaT Pharma advances its microbiome ecosystem therapies with new preclinical evidence showing enhanced patient immunotherapy responses.
Experimental gene-silencing drug lepodisiran delivers long-lasting reduction of cardiovascular risk factor, while Spinogenix launches trial for novel synaptic …
The sudden departure of FDA’s Peter Marks raises uncertainty across the biopharma sector amid ongoing regulatory scrutiny and …
Already a subscriber? Log in